National Donate Life Month is celebrated every April, with events held throughout the month to increase awareness about organ donation. This month also encourages more individuals to register as donors while also honoring people who have changed lives by donating.
The surgical procedures made possible through organ donation save and also change the lives of many. It is estimated that more than 100,000 people in America are waiting for life-saving organ transplants. In addition to a shortage of viable organs, the financial costs associated with organ transplants are astounding. This factor limits people in need of transplants as well as transplant centers.
Let’s look at how public funding, philanthropy and collaboration could help patients in need of transplants, starting with some of the issues the organ donation network faces.
It is no secret that the cost of healthcare in America is high. Without reliable insurance coverage, it’s almost impossible for the average patient to cover transplant costs as well as the associated expenses of said procedure. For instance, a patient who needs a transplant may have to relocate for a certain amount of time to receive the care needed if they do not reside close to a transplant center providing the procedure, which adds to their expenses.
Additionally, all transplantation centers in America are governed by one parent agency, the Health Resources and Services Administration. Heavy dependence on this body has led to shortages in funding, which makes it hard to fulfill the need for transplant services in the community while also making many miss transplant opportunities that would improve their quality of life.
How can these barriers be overcome?
Implementing changes that address some of the financial and systemic shortcomings in the transplant industry will go a long way. For example, the Nevada Donor Network is focused on developing a Transplant Institute. The independent, nonprofit organization will combine the capacity of the state’s whole transplant-related system with sufficient resources under one coordinated umbrella.
The institute, to be named the Nevada Transplant Institute, will be funded by philanthropy, which will help address the lack of funding for transplant centers caused by budgetary limitations of parent agencies. The diversification of revenue sources will also allow patients to receive help, regardless of their socioeconomic status, household income or insurance plan.
In addition to this, amendments will also be made to the National Organ Transplant Act. These changes will allow resources to be better allocated while also fostering competition and innovation within this sector.
For-profit businesses such as Aditxt Inc. (NASDAQ: ADTX) are also contributing to this effort in their own way by developing immunotherapies that reduce the likelihood of transplanted organs being rejected by the host.
NOTE TO INVESTORS: The latest news and updates relating to Aditxt Inc. (NASDAQ: ADTX) are available in the company’s newsroom at https://ibn.fm/ADTX
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
